A joint team of researchers from Rensselaer, Northwestern University and the Icahn School of Medicine at Mount Sinai has developed a methodology that could improve the treatment of aggressive glioblastoma brain tumors. The process, which combines medical imaging and bioprinting technologies, can help scientists to better understand the complex structure of the tumor type.
Glioblastomas are quickly growing malignant tumors in the brain that are made up of many different cell types, which makes them challenging to treat. Today, glioblastoma treatment typically involves a combination of surgery, radiation and chemotherapy. Even then, treatment only results in an average survival of 11-15 months.
The new process pioneered by the research group allows for a greater understanding of what happens in the body when glioblastoma cells are present thanks to the use of a 3D bioprinted tumor cell model.